Home/Filings/4/0001415889-24-023216
4//SEC Filing

Piekos Brian 4

Accession 0001415889-24-023216

CIK 0001348911other

Filed

Sep 10, 8:00 PM ET

Accepted

Sep 11, 4:34 PM ET

Size

5.8 KB

Accession

0001415889-24-023216

Insider Transaction Report

Form 4
Period: 2024-09-09
Piekos Brian
Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2024-09-09+100,000100,000 total
    Exercise: $11.87Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]The option vests over a 4 year period: 25% on September 9, 2025, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date.

Issuer

KalVista Pharmaceuticals, Inc.

CIK 0001348911

Entity typeother

Related Parties

1
  • filerCIK 0001815308

Filing Metadata

Form type
4
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 4:34 PM ET
Size
5.8 KB